Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04416919 · ClinicalTrials.gov registry record · NA
Assessment of N-95 Facemask for Use in COVID-19 Pandemic in Case of Shortage of Personal Protective Equipment
A NA study of Corona Virus Infection and Disease Prevention, sponsored by University of Oklahoma.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT04416919: Completed NA study of Corona Virus Infection and Disease Prevention, sponsored by University of Oklahoma.
NCT04416919 is a NA study of Corona Virus Infection and Disease Prevention that has completed, run by University of Oklahoma. The registered enrollment target is 20 participants, below the 585-participant average among 28 other Corona Virus Infection trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04416919, a NA study of Corona Virus Infection and Disease Prevention, has completed, sponsored by University of Oklahoma.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to assess the safety and efficiency of an assembled modified mask in protecting health care workers against Coronavirus in case of any personal protective equipment shortage. At least 20 healthy participants will be recruited to try the modified mask. The modified masks will be made from masks that are already available as well as filters available in the pulmonary department at the Oklahoma City VA Health Care System
Primary Outcome
Conduct a quantitative fit test and calculate the percentage of participants who pass the test.
Conditions Studied
Interventions
- OTHER Assembled mask
Study Locations (1)
Oklahoma
- Oklahoma City VA Health Care System - Oklahoma City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2020-05-20 |
| Est. Completion | 2022-01-20 |
| Phase | NA |
What the finished NCT04416919 record still lists
NCT04416919 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 585-participant average among 28 other Corona Virus Infection trials with a reported enrollment target (97% lower).
The record links to 2 conditions, with Corona Virus Infection appearing as the primary indexed condition, and to 1 intervention - of which Assembled mask is the first listed.
NCT04416919 reports a single indexed study location in Oklahoma.
Frequently Asked Questions
What is clinical trial NCT04416919 about?
NCT04416919 is a clinical study titled "Assessment of N-95 Facemask for Use in COVID-19 Pandemic in Case of Shortage of Personal Protective Equipment". The purpose of this study is to assess the safety and efficiency of an assembled modified mask in protecting health care workers against Coronavirus in case of any personal protective equipment shortage. At least 20 healthy participants will be recruited to try the modified mask. The modified masks ...
What is the current status of trial NCT04416919?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2020-05-20. Estimated completion is 2022-01-20.
What conditions does trial NCT04416919 study?
This clinical trial studies the following conditions: Corona Virus Infection, Disease Prevention.
What interventions are being tested in trial NCT04416919?
The interventions under investigation include: Assembled mask (OTHER).
Who is sponsoring clinical trial NCT04416919?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04416919 being conducted?
This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Corona Virus Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04416919's enrollment target sits among peer trials
20 27th of 28 higher than 2 of 28 other Corona Virus Infection trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Corona Virus Infection trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study To Evaluate The Performance of the Lucira Health All-In-One COVID-19 Test Kit vs Hologic Panther Fusion
COMPLETED · NA
-
Early PP With HFNC Versus HFNC in COVID-19 Induced Moderate to Severe ARDS
COMPLETED · NA
-
A Follow On Community Testing Study To Evaluate The Performance of the Lucira COVID-19 All-In-One Test Kit
COMPLETED · NA
-
Computer Cognitive Training for Post-acute COVID-19 Syndrome
COMPLETED · NA
-
Photo-Protection Trial (NB-UVB vs. Placebo) in High-risk Hospitalized COVID-19 Patients
COMPLETED · NA
-
Community Collaboration to Combat COVID-19 (C-FORWARD)
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI